MENU

BLPH Bellerophon Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

a developer of products at the intersection of drugs and devices

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

BLPH is expected to report earnings to fall 31.25% to -33 cents per share on November 08

Bellerophon Therapeutics, Inc. BLPH Stock Earnings Reports
Q3'23
Est.
$-0.33
Q2'23
Missed
by $0.03
Q1'23
Beat
by $0.75
Q4'22
Missed
by $0.05
Q3'22
Beat
by $0.06
The last earnings report on August 03 showed earnings per share of -47 cents, missing the estimate of -44 cents. With 297.00 shares outstanding, the current market capitalization sits at 452.61K.
A.I. Advisor
published General Information

General Information

a developer of products at the intersection of drugs and devices

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
184 Liberty Corner Road
Phone
+1 908 574-4770
Employees
18
Web
https://www.bellerophon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

BLPH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BLPH has been loosely correlated with SNBIF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BLPH jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLPH
1D Price
Change %
BLPH100%
N/A
SNBIF - BLPH
61%
Loosely correlated
N/A
TBPH - BLPH
28%
Poorly correlated
-1.14%
KNBIF - BLPH
23%
Poorly correlated
N/A
LIPO - BLPH
22%
Poorly correlated
-4.55%
AURA - BLPH
22%
Poorly correlated
-3.48%
More

Groups containing BLPH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLPH
1D Price
Change %
BLPH100%
N/A
drugs
theme (254 stocks)
-3%
Poorly correlated
-1.67%
medical research
theme (126 stocks)
-4%
Poorly correlated
-1.85%
medical service
theme (154 stocks)
-5%
Poorly correlated
-1.97%